178 related articles for article (PubMed ID: 31618515)
41. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
[TBL] [Abstract][Full Text] [Related]
42. Combining oncolytic virus with FDA approved pharmacological agents for cancer therapy.
Zhang W; Chen CC; Ning J
Expert Opin Biol Ther; 2021 Feb; 21(2):183-189. PubMed ID: 32799567
[TBL] [Abstract][Full Text] [Related]
43. Postvaccinal sarcomas in the cat: histology and immunohistochemistry.
Hendrick MJ; Brooks JJ
Vet Pathol; 1994 Jan; 31(1):126-9. PubMed ID: 8140720
[No Abstract] [Full Text] [Related]
44. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.
Poirier VJ; Thamm DH; Kurzman ID; Jeglum KA; Chun R; Obradovich JE; O'Brien M; Fred RM; Phillips BS; Vail DM
J Vet Intern Med; 2002; 16(6):726-31. PubMed ID: 12465772
[TBL] [Abstract][Full Text] [Related]
45. Vaccine-associated feline sarcomas.
Morrison WB; Starr RM;
J Am Vet Med Assoc; 2001 Mar; 218(5):697-702. PubMed ID: 11280397
[No Abstract] [Full Text] [Related]
46. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
[TBL] [Abstract][Full Text] [Related]
47. Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells.
Nguyen TL; Wilson MG; Hiscott J
Cytokine Growth Factor Rev; 2010; 21(2-3):153-9. PubMed ID: 20395162
[TBL] [Abstract][Full Text] [Related]
48. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model.
Spugnini EP; Baldi A; Vincenzi B; Bongiorni F; Bellelli C; Citro G; Porrello A
Cancer Chemother Pharmacol; 2007 Feb; 59(3):375-81. PubMed ID: 16807731
[TBL] [Abstract][Full Text] [Related]
49. Metronomic chemotherapy.
Mutsaers AJ
Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
[TBL] [Abstract][Full Text] [Related]
50. Feline injection site-associated sarcoma: Is it a reason to critically evaluate our vaccination policies?
Kirpensteijn J
Vet Microbiol; 2006 Oct; 117(1):59-65. PubMed ID: 16769184
[TBL] [Abstract][Full Text] [Related]
51. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
Patil SS; Gentschev I; Nolte I; Ogilvie G; Szalay AA
J Transl Med; 2012 Jan; 10():3. PubMed ID: 22216938
[TBL] [Abstract][Full Text] [Related]
52. Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.
Le Boeuf F; Selman M; Son HH; Bergeron A; Chen A; Tsang J; Butterwick D; Arulanandam R; Forbes NE; Tzelepis F; Bell JC; Werier J; Abdelbary H; Diallo JS
Int J Cancer; 2017 Sep; 141(6):1257-1264. PubMed ID: 28568891
[TBL] [Abstract][Full Text] [Related]
53. Feline Injection Site Sarcomas: Data from Switzerland 2009-2014.
Graf R; Guscetti F; Welle M; Meier D; Pospischil A
J Comp Pathol; 2018 Aug; 163():1-5. PubMed ID: 30213367
[TBL] [Abstract][Full Text] [Related]
54. Radiation as a therapeutic modality in sarcomas of the soft tissue.
Suit H; Spiro I
Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
[TBL] [Abstract][Full Text] [Related]
55. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
56. Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993).
Lester S; Clemett T; Burt A
J Am Anim Hosp Assoc; 1996; 32(2):91-5. PubMed ID: 8680926
[TBL] [Abstract][Full Text] [Related]
57. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy?
Atherton MJ; Lenz JA; Mason NJ
Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517
[TBL] [Abstract][Full Text] [Related]
58. Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma.
Wilkinson MJ; Smith HG; Pencavel TD; Mansfield DC; Kyula-Currie J; Khan AA; McEntee G; Roulstone V; Hayes AJ; Harrington KJ
Int J Cancer; 2016 Sep; 139(6):1414-22. PubMed ID: 27116656
[TBL] [Abstract][Full Text] [Related]
59. The potential role of inflammation in the development of postvaccinal sarcomas in cats.
Macy DW; Hendrick MJ
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):103-9. PubMed ID: 8825569
[TBL] [Abstract][Full Text] [Related]
60. Feline vaccine-associated sarcomas: current studies on pathogenesis.
Hendrick MJ
J Am Vet Med Assoc; 1998 Nov; 213(10):1425-6. PubMed ID: 9828935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
